Peter C. Adamson
Impact in
Papers in
-
- Retinoids in leukemia and cellular processes 20
- Cancer therapeutics and mechanisms 19
-
- Acute Lymphoblastic Leukemia research 41
- Co-authors
- Susan M. Blaney (83 shared papers)Brigitte C. Widemann (26 shared papers)Frank M. Balis (66 shared papers)Mark Krailo (39 shared papers)Ashish M. Ingle (27 shared papers)Gregory H. Reaman (20 shared papers)Elizabeth Fox (26 shared papers)Brenda J. Weigel (15 shared papers)
- Journals
- Journal of Clinical Oncology (55 papers)Pediatric Blood & Cancer (34 papers)Clinical Cancer Research (15 papers)Cancer Chemotherapy and Pharmacology (14 papers)Cancer (9 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Peter C. Adamson
236 papers receiving 11.2k citations
Peter C. Adamson's Hit Papers
Peers
Comparison fields: 5 of 154
- Neurology 1.7k
- Genetics 943
- Pediatrics, Perinatology and Child Health 1.5k
- Hematology 908
- Oncology 2.1k
Countries citing papers authored by Peter C. Adamson
This map shows the geographic impact of Peter C. Adamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Adamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Adamson more than expected).
Fields of papers citing papers by Peter C. Adamson
This network shows the impact of papers produced by Peter C. Adamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Adamson. The network helps show where Peter C. Adamson may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter C. Adamson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 238 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Understanding and Managing Methotrexate Nephrotoxicity Hit paper breakdown → | 2006 | 546 |
| 2 | Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study Hit paper breakdown → | 2013 | 484 |
| 3 | 2010 | 386 | |
| 4 | Declining childhood and adolescent cancer mortality Hit paper breakdown → | 2014 | 371 |
| 5 | 2017 | 254 | |
| 6 | 2004 | 247 | |
| 7 | 2004 | 235 | |
| 8 | 2008 | 202 | |
| 9 | 2012 | 190 | |
| 10 | 2007 | 178 | |
| 11 | 2008 | 170 | |
| 12 | 2005 | 166 | |
| 13 | 2010 | 150 | |
| 14 | 2020 | 149 | |
| 15 | 2011 | 148 | |
| 16 | 2008 | 147 | |
| 17 | 2006 | 132 | |
| 18 | 2013 | 130 | |
| 19 | 2008 | 123 | |
| 20 | 1992 | 119 |
About Peter C. Adamson
Peter C. Adamson is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Neurology, Oncology and Pediatrics, Perinatology and Child Health, having authored 238 papers that have together received 11.5k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (41 papers), Neuroblastoma Research and Treatments (33 papers), Retinoids in leukemia and cellular processes (20 papers), Childhood Cancer Survivors' Quality of Life (20 papers), Cancer therapeutics and mechanisms (19 papers), Antibiotics Pharmacokinetics and Efficacy (13 papers), Pharmaceutical studies and practices (12 papers) and Chronic Myeloid Leukemia Treatments (9 papers). The work is most often cited by research in Neurology (1.7k citations), Genetics (943 citations), Pediatrics, Perinatology and Child Health (1.5k citations), Hematology (908 citations) and Oncology (2.1k citations). Peter C. Adamson has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Susan M. Blaney, Brigitte C. Widemann, Frank M. Balis, Mark Krailo, Ashish M. Ingle, Gregory H. Reaman, Elizabeth Fox, Brenda J. Weigel, Stephan D. Voss and Joel M. Reid. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.